Horowitz B, Lazo A, Grossberg H, Page G, Lippin A, Swan G
V.I. Technologies, Inc., New York, NY 10032, USA.
Vox Sang. 1998;74 Suppl 1:203-6. doi: 10.1111/j.1423-0410.1998.tb05473.x.
Solvent/Detergent (SD) is an extraordinarily effective means for eliminating enveloped viruses from plasma and plasma products. The safety margin suggested by the rapid and complete kill of enveloped viruses observed in the laboratory has been confirmed repeatedly by groups worldwide and by thirteen years of routine clinical use encompassing an estimated 35 million doses of a wide variety of products. Throughout this time, there has not been a single documented case of enveloped virus transmission by an SD-treated product. This record of safety spawned the development of SD-treated plasma as a substitute for fresh frozen plasma (FFP) and has encouraged the adoption of SD for the treatment of non-blood products such as monoclonal antibodies and those derived from recombinant DNA procedures. This review summarizes the use of SD treatment, including its use in combination with other viral elimination procedures, and also summarizes Vitex's initial experience in the manufacture of SD-Plasma, recently licensed by the U.S. FDA.
溶剂/去污剂(SD)是一种从血浆和血浆制品中去除包膜病毒的极其有效的方法。实验室中观察到的包膜病毒快速且完全被灭活所表明的安全边际,已被全球多个团队以及13年的常规临床使用反复证实,这期间估计使用了3500万剂各种各样的产品。在此期间,没有一例关于经SD处理的产品传播包膜病毒的记录案例。这种安全记录促使了经SD处理的血浆作为新鲜冰冻血浆(FFP)替代品的开发,并鼓励将SD用于治疗非血液制品,如单克隆抗体和那些源自重组DNA程序的制品。本综述总结了SD处理的应用,包括其与其他病毒去除程序联合使用的情况,还总结了Vitex公司在生产SD血浆方面的初步经验,该产品最近已获得美国食品药品监督管理局(FDA)的许可。